Andreas Kronbichler: The Changing Landscape of CV Risk in ANCA-Associated Vasculitis
Andreas Kronbichler, Director at Department of Internal Medicine IV, Medical University of Innsbruck, shared post on LinkedIn about a recent article he and his colleague co-authored, published in Rheumatology, adding:
“New publication alert from our research group!
Cardiovascular risk trajectories in patients with ANCA-associated vasculitis change over time!
The risk of most cardiovascular events increases before diagnosis and peaks at the time of diagnosis!
VTE has been reported in up to 18% of ANCA-GN, and is clearly associated with inflammation.
This study shows a CVD-VTE hazard ratio of 7.7 during the initial phase of the disease, using a large population-based cohort from Sweden.
The Editorial was written by Clemens Untersulzner!
Just published in Rheumatology.”
Title: Cardiovascular risk in ANCA-associated vasculitis: a plea for early intervention
Autors: Clemens Untersulzner, Andreas Kronbichler
Stay updated with Hemostatis today.
-
Oct 21, 2026, 08:21Pham Quy: Taking Stroke Awareness Beyond Hospitals and Into the Community
-
Oct 21, 2026, 07:15Mahmoud Saad: Successful Mechanical Thrombectomy for Right Atrial Thrombosis
-
Oct 21, 2026, 06:55Hunain Shahbaz: Extended Dual Antiplatelet Therapy Beyond 12 Months After Drug-Eluting Stent Implantation
-
Oct 21, 2026, 06:19Dawood Findakly: When Should Anticoagulation Be Held or Resumed?
-
Oct 21, 2026, 03:36Steve Watson: Ligand Epitope Ratios Influence Antagonist Inhibition
-
Oct 21, 2026, 03:18Stephen D. Coombs: Superficial Venous Thrombosis in Athletes and Importance of Early Recognition and Referral
-
Oct 21, 2026, 02:52Aymar Akilimali: Bleeding During Anticoagulation as a Potential Signal of Occult Cancer
-
Oct 21, 2026, 00:58Anees Ur Rahman: Completing a Two-Week Clinical Rotation at Haemophilia Treatment Centre Rawalpindi
-
Oct 21, 2026, 00:56Caitlyn Mooney: Pulmonary Embolism in Athletes, Recognition and Return to Sport